What is Aebi Schmidt Holding's north america — R&D?

Aebi Schmidt Holding (AEBI) reported north america — R&D of $1.63M in Q1 2026.

How has Aebi Schmidt Holding's north america — R&D changed year-over-year?

Aebi Schmidt Holding's north america — R&D increased by 171.7% year-over-year, from $601K to $1.63M.

What does north america — R&D mean?

This represents the expenses incurred by the North American segment to develop new products, improve existing technologies, or enhance manufacturing processes. It is a key indicator of the segment's commitment to innovation and long-term competitive positioning. Sustained investment in this area is typically essential for maintaining market relevance and driving future growth.

Aebi Schmidt Holding (AEBI) North America — R&D

Screener

Other segment segments

Europe and ROW

$5.07M+25.9%

Similar metrics at other companies

HPNorth America Solutions — R&D

$6.02M-21.0%

BRCAmericas & Asia — R&D

$16.95M+27.3%

MSA

MSAAmericas segment — R&D

$9.64M+2.9%

INSMARIKAYCE external R&D expenses — R&D

$6.23M-43.4%

INSMBrensocatib external R&D expenses — R&D

$13.83M-58.8%

INSMTPIP external R&D expenses — R&D

$38.94M+88.6%

Other financials

Income statement

See full

Revenue$455.5M+82.8%

Gross profit$87.4M+63.9%

Operating income$15.4M+6.8%

Net income$695.0K-66.5%

EPS (diluted)$0.01-80.0%

Balance sheet

See full

Cash & equivalents$115.9M+142%

Total debt$794.1M+52.8%

Total equity$814.7M+119%

Total assets$2.0B+79.7%

Cash flow

See full

Operating cash flow-$17.7M+33.2%

CapEx$1.9M-37.8%

Free cash flow-$19.7M+33.7%

Valuation

See full

Market cap$1.02B+17.8%

Enterprise value$1.69B—

P/E121.6×—

P/S0.6×—

Profitability

See full

Gross margin19.5%-1.2pp

Operating margin4.3%-1.6pp

Net margin0.5%-1.7pp

FCF margin3.3%+2.8pp

Returns & leverage

See full

Return on equity1.4%-5.3pp

Debt / equity1×-0.4×

Current ratio2×-0.1×

Where this comes from

Reported directly by Aebi Schmidt Holding in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Aebi Schmidt Holding’s 10-Q, filed May 14, 2026.

Filed: May 14, 2026, 7:00 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0001628280-26-034785

Line item	Three Months Ended March 31, 2026 / North America	Three Months Ended March 31, 2026 / Europe and ROW	Three Months Ended March 31, 2025 / North America	Three Months Ended March 31, 2025 / Europe and ROW
Sales	$337,322	$118,223	$147,291	$101,895
Cost of products sold	276,035	92,121	116,909	78,971
Research and development	1,633	5,068	601	4,026
Selling, general and administrative	39,322	19,225	12,534	18,190
Other segment items(1)	(6,031)	(4,945)	(1,789)	(1,533)
Segment Adjusted EBITDA	$26,363	$6,754	$19,036	$2,241

Item 1. Financial Statements.

FAQ

What is Aebi Schmidt Holding's north america — R&D?: Aebi Schmidt Holding (AEBI) reported north america — R&D of $1.63M in Q1 2026.
How has Aebi Schmidt Holding's north america — R&D changed year-over-year?: Aebi Schmidt Holding's north america — R&D increased by 171.7% year-over-year, from $601K to $1.63M.
What does north america — R&D mean?: This represents the expenses incurred by the North American segment to develop new products, improve existing technologies, or enhance manufacturing processes. It is a key indicator of the segment's commitment to innovation and long-term competitive positioning. Sustained investment in this area is typically essential for maintaining market relevance and driving future growth.